Chandler P - Search Results

1

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL. Munn DH, et al. Among authors: chandler p. J Clin Invest. 2004 Jul;114(2):280-90. doi: 10.1172/JCI21583. J Clin Invest. 2004. PMID: 15254595 Free PMC article.

2

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.

Baban B, Hansen AM, Chandler PR, Manlapat A, Bingaman A, Kahler DJ, Munn DH, Mellor AL. Baban B, et al. Int Immunol. 2005 Jul;17(7):909-19. doi: 10.1093/intimm/dxh271. Epub 2005 Jun 20. Int Immunol. 2005. PMID: 15967784

3

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.

Mellor AL, Baban B, Chandler PR, Manlapat A, Kahler DJ, Munn DH. Mellor AL, et al. J Immunol. 2005 Nov 1;175(9):5601-5. doi: 10.4049/jimmunol.175.9.5601. J Immunol. 2005. PMID: 16237046

4

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

Manlapat AK, Kahler DJ, Chandler PR, Munn DH, Mellor AL. Manlapat AK, et al. Eur J Immunol. 2007 Apr;37(4):1064-71. doi: 10.1002/eji.200636690. Eur J Immunol. 2007. PMID: 17343295 Free article.

5

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA 3rd, Kahler DJ, Pihkala J, Soler AP, Munn DH, Prendergast GC, Mellor AL. Muller AJ, et al. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8. doi: 10.1073/pnas.0806173105. Epub 2008 Oct 24. Proc Natl Acad Sci U S A. 2008. PMID: 18952840 Free PMC article.

6

IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.

Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, Mellor AL. Baban B, et al. J Immunol. 2009 Aug 15;183(4):2475-83. doi: 10.4049/jimmunol.0900986. Epub 2009 Jul 27. J Immunol. 2009. PMID: 19635913 Free PMC article.

7

B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.

Johnson BA 3rd, Kahler DJ, Baban B, Chandler PR, Kang B, Shimoda M, Koni PA, Pihkala J, Vilagos B, Busslinger M, Munn DH, Mellor AL. Johnson BA 3rd, et al. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10644-8. doi: 10.1073/pnas.0914347107. Epub 2010 May 24. Proc Natl Acad Sci U S A. 2010. PMID: 20498068 Free PMC article.

8

Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

Sharma MD, Hou DY, Baban B, Koni PA, He Y, Chandler PR, Blazar BR, Mellor AL, Munn DH. Sharma MD, et al. Immunity. 2010 Dec 14;33(6):942-54. doi: 10.1016/j.immuni.2010.11.022. Epub 2010 Dec 9. Immunity. 2010. PMID: 21145762 Free PMC article.

9

Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.

Makala LH, Baban B, Lemos H, El-Awady AR, Chandler PR, Hou DY, Munn DH, Mellor AL. Makala LH, et al. J Infect Dis. 2011 Mar 1;203(5):715-25. doi: 10.1093/infdis/jiq095. Epub 2011 Jan 31. J Infect Dis. 2011. PMID: 21282196 Free PMC article.

10

Physiologic control of IDO competence in splenic dendritic cells.

Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, Sharpe ML, Francisco LM, Sharpe AH, Blazar BR, Munn DH, Mellor AL. Baban B, et al. J Immunol. 2011 Sep 1;187(5):2329-35. doi: 10.4049/jimmunol.1100276. Epub 2011 Aug 3. J Immunol. 2011. PMID: 21813777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

473 results

Search Page